Marina L Erenshtein

Title: Marina L Erenshtein: Innovator in Pharmaceutical Compounds

Introduction

Marina L Erenshtein is a notable inventor based in Riga, SU. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for medical applications. With a total of 2 patents, her work focuses on innovative solutions for treating hypertensive diseases.

Latest Patents

Among her latest patents, Marina has developed 3-(2,2,2-trisubstituted hydrazinium) propionates, which are novel compounds with a general formula that includes various alkyl and aryl groups. Additionally, she has created a pharmaceutical preparation aimed at treating hypertensive disease and myocardial infarction, which features (1,1-dimethyl-3-oxopyrazolidin-1-io-4-yl)acetate as an active ingredient, combined with a pharmaceutically acceptable vehicle.

Career Highlights

Marina's career is marked by her dedication to pharmaceutical innovation. Her research has led to advancements in treatments that address critical health issues, showcasing her commitment to improving patient outcomes through her inventions.

Collaborations

Marina has collaborated with esteemed colleagues such as Gunar A Bremanis and Ivars Y Kalvinsh, contributing to a dynamic research environment that fosters innovation and development in her field.

Conclusion

Marina L Erenshtein stands out as a pioneering inventor in the pharmaceutical industry, with her patents reflecting her expertise and dedication to advancing medical treatments. Her contributions are vital in the ongoing quest for effective healthcare solutions.